Design of Experiment Optimization of Artificial Bone Construct Fabrication Via Direct Ink Writing of Hydroxyapatite

Author(s):  
C. M. Gigliotti ◽  
R. W. Marks ◽  
Z. R. Wilczynski ◽  
G. S. Lewis ◽  
H. J. Donahue ◽  
...  
2012 ◽  
Vol 3 (1) ◽  
pp. 148-150
Author(s):  
Dr. G. H. Upadhyay Dr. G. H. Upadhyay ◽  
◽  
M. M. Kadri M. M. Kadri ◽  
U. V. Shah U. V. Shah
Keyword(s):  

2018 ◽  
Vol 69 (8) ◽  
pp. 1944-1948 ◽  
Author(s):  
Adina Turcu Stiolica ◽  
Maria Viorica Bubulica ◽  
Oana Elena Nicolaescu ◽  
Octavian Croitoru ◽  
Mariana Popescu ◽  
...  

A design of experiment (DoE) approach is presented for the optimization of Alendronate-hydroxyapatite nanoparticles� synthesis. The synthesis was performed using the chemical precipitation technique from calcium nitrate, diammonium hydrogen phosphate and alendronate. Synthesis temperature, reactant addition rate and ripening time were chosen as the most relevant experimental factors for our synthesis. Design of Experiments was used in order to measure these conclusive process parameters and their effect on controlling some final nanoparticles parameters, such us: alendronate incorporation efficiency (IncorporationEfficiency, %), hydroxyapatite crystallite size (Size_XRD, nm), hydroxyapatite particle size distribution (Size_DLS, �). Our study found that better HA-AL incorporation efficiency and small nonoparticles can be obtained using the following chemical process parameters: reaction temperature 30oC or smaller, ripening time 108h and addition rate 0.1mol/min. The analysis of more than one nanoparticles characteristics was possible using DoE software, MODDE 9.1. Thus, hydroxyapatite-alendronate incorporation efficiency should be expected to increase with decreasing temperature below 300C, increasing the maturate time at least 108h, at an addition rate of 0.1mol/min, in an N2 atmosphere. The same conditions will ensure nanoparticles small size that would be more desirable for the application of implants.


2021 ◽  
Vol 23 ◽  
pp. 101005
Author(s):  
Kai Huang ◽  
Hamada Elsayed ◽  
Giorgia Franchin ◽  
Paolo Colombo

Polymers ◽  
2020 ◽  
Vol 13 (1) ◽  
pp. 77
Author(s):  
Enric Casanova-Batlle ◽  
Antonio J. Guerra ◽  
Joaquim Ciurana

Bioresorbable cardiovascular applications are increasing in demand as fixed medical devices cause episodes of late restenosis. The autologous treatment is, so far, the gold standard for vascular grafts due to the similarities to the replaced tissue. Thus, the possibility of customizing each application to its end user is ideal for treating pathologies within a dynamic system that receives constant stimuli, such as the cardiovascular system. Direct Ink Writing (DIW) is increasingly utilized for biomedical purposes because it can create composite bioinks by combining polymers and materials from other domains to create DIW-printable materials that provide characteristics of interest, such as anticoagulation, mechanical resistance, or radiopacity. In addition, bioinks can be tailored to encounter the optimal rheological properties for the DIW purpose. This review delves into a novel emerging field of cardiovascular medical applications, where this technology is applied in the tubular 3D printing approach. Cardiovascular stents and vascular grafts manufactured with this new technology are reviewed. The advantages and limitations of blending inks with cells, composite materials, or drugs are highlighted. Furthermore, the printing parameters and the different possibilities of designing these medical applications have been explored.


Sign in / Sign up

Export Citation Format

Share Document